The global CAR T-cell therapy market is experiencing explosive growth, driven by increasing demand for innovative cancer treatments. Ongoing studies have demonstrated the efficacy of CAR T-cell therapy in treating a number of cancers, leading to growing patient approval. Key drivers fueling market growth include advancements in genetic engineerin

The global antibody therapeutics market is experiencing a period of remarkable growth. This expansion can be attributed to several factors, such as the increasing prevalence of chronic diseases, advancements in biotechnology, and growing acceptance of biologics. The market is projected to expand at a compounding annual growth rate of Z% during the